Celera CORP (CRA) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 208 transactions totaling $141.6M, demonstrating a bullish sentiment with $140.0M in net insider flow. The most recent transaction on May 17, 2011 involved a purchase of 24,000 shares valued at $192.7K.
No significant insider buying has been recorded for CRA in the recent period.
No significant insider selling has been recorded for CRA in the recent period.
Based on recent SEC filings, insider sentiment for CRA is bullish with an Insider Alignment Score of 99/100 and a net flow of $140.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Celera CORP (CRA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading CRA stock, having executed 208 transactions in the past 90 days. The most active insider is Diagnostics Inc Quest (Executive), who has made 4 transactions totaling $46.6M.
Get notified when executives and directors at CRA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 17, 2011 | Fund II Lp Biotechnology Value | Executive | Purchase | 24,000 | $8.03 | $192.7K | |
| May 17, 2011 | Fund II Lp Biotechnology Value | Executive | Purchase | 35,300 | $8.03 | $283.5K | |
| May 17, 2011 | Fund II Lp Biotechnology Value | Executive | Purchase | 92,000 | $8.03 | $738.8K | Large |
| May 16, 2011 | Fund II Lp Biotechnology Value | Executive | Purchase | 80,600 | $8.03 | $647.2K | Large |
| May 16, 2011 | Fund II Lp Biotechnology Value | Executive | Purchase | 19,900 | $8.03 | $159.8K | |
| May 16, 2011 | Fund II Lp Biotechnology Value | Executive | Purchase | 30,150 | $8.03 | $242.1K | |
| May 13, 2011 | Fund II Lp Biotechnology Value | Executive | Purchase | 1,550 | $8.03 | $12.4K | |
| May 13, 2011 | Fund II Lp Biotechnology Value | Executive | Purchase | 650 | $8.03 | $5.2K | |
| May 13, 2011 | Fund II Lp Biotechnology Value | Executive | Purchase | 6,600 | $8.03 | $53.0K | |
| May 12, 2011 | Llc Bvf Investments | Executive | Purchase | 112,000 | $8.03 | $899.4K | Large |
| May 12, 2011 | Llc Bvf Investments | Executive | Purchase | 46,400 | $8.03 | $372.6K | |
| May 12, 2011 | Llc Bvf Investments | Executive | Purchase | 32,000 | $8.03 | $257.0K | |
| May 12, 2011 | Corp Spark Acquisition | Executive | Purchase | 100,000 | $8.06 | $806.0K | Large |
| May 12, 2011 | Corp Spark Acquisition | Executive | Purchase | 328,078 | $8.00 | $2.6M | Large |
| May 11, 2011 | Llc Bvf Investments | Executive | Purchase | 575,900 | $8.03 | $4.6M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 82 | $140.8M | 95.3% |
Tender(U) | 19 | $3.8M | 2.6% |
Payment(F) | 44 | $1.9M | 1.3% |
Sale(S) | 4 | $792.8K | 0.5% |
Exercise(M) | 6 | $544.2K | 0.4% |
Disposition(D) | 29 | $0 | 0.0% |
Award(A) | 21 | $0 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Insiders at Celera CORP are accumulating shares at an accelerated pace. With 21 insiders making 208 transactions totaling $140.8M in purchases versus $792.8K in sales, the net buying activity of $140.0M signals strong executive confidence. Diagnostics Inc Quest (Executive) leads the buying activity with $46.6M in transactions across all time.